Boston Scientific Corp.

Company Snapshot

Founded: 1979
Entity Type: Public
Employees: 59,000
Region: U.S.
Revenue: $20,074.0 Millions
Revenue Year: 2025
Segment: Cardiovascular
Headquarter: Massachusetts, U.S.
Key Geographics: U.S., Europe, Middle East and Africa, Asia-Pacific, Latin America, Canada
Corporate Address: 300 Boston Scientific Way Marlborough, Massachusetts, 01752-1234 U.S. Tel: +1-508-683-4000 Web: www.bostonscientific.com

Company Overview

Boston Scientific Corp. is a medical device company that develops, manufactures, and commercializes minimally invasive medical technologies. Its operations span product development, clinical research, manufacturing, regulatory affairs, and global sales.

Boston Scientific operates through multiple business segments, with a significant focus on cardiovascular, electrophysiology, and interventional therapies. Within cardiovascular care, it provides devices for cardiac rhythm management, interventional cardiology, peripheral interventions, and structural heart disease. Its cardiac rhythm management portfolio includes implantable pacemakers, cardiac resynchronization therapy pacemakers (CRT-P), implantable cardioverter defibrillators (ICDs), and remote patient monitoring systems.

Boston Scientific serves hospitals and healthcare providers worldwide through a combination of direct sales organizations and distribution partners, maintaining a broad geographic footprint across North America, Europe, Asia-Pacific, and emerging markets.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Boston Scientific Corp. In Reports

Pacemakers: Global Markets

BCC Research detailed report on pacemaker market revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period from 2025 through 2030.

Technologies for Long-Term Care and Home Healthcare: Global Markets

According to BCC Research detailed report on technologies for long-term care and home healthcare market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates through 2030.

Global Markets and Technologies for Advanced Drug Delivery Systems - Focus on Routes of Administration

According to BCC Research detailed report on advanced drug delivery systems market estimates, data will be provided for 2024 because of the base year, with forecasts for 2025 and forecast value for 2030.

Company's Business Segments

  • MedSurg : Endoscopy, Urology, and Neuromodulation
  • Cardiovascular : Interventional Cardiology & Vascular Therapies, Electrophysiology Cardiac Rhythm Management, Interventional Oncology & Embolization

Applications/End User Industries

  • Electrophysiology
  • Gastroenterology
  • Interventional Cardiology
  • Neurological Surgery
  • Orthopedic Surgeons
  • Pain Medicine
  • Pulmonology
  • Structural Heart
  • Urology
  • Vascular Surgery
AI Sentiment